Abstract
Since the advent of genome-wide association studies, there have been rapid developments in genomics research into Alzheimer’s disease (AD). Research in the past decade has brought forward many novel AD-susceptibility loci, and has identified many new biological pathways influencing AD pathology. These new insights are crucial for our understanding of the biology of AD, and offer new opportunities for medical targets and interventions for the prevention and/or treatment of AD. Here, we review the most important developments in genomics research for AD since the advent of genome-wide association studies. Moreover, we provide a brief overview of other -omics approaches for AD, and elaborate on the advantages of multiple -omics approaches for investigating complex disorders such as AD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
